Springing Into Action
This time of year, signs of growth are everywhere from new leaves on trees to nests filled with eggs. In this Spring issue of the Visionary, I am happy to share with you how ROI research is blossoming through new awards and outcomes.
ROI has launched the call for nominations for the 2022 Publication Award and we are looking forward to seeing many outstanding articles submitted for consideration again this year. Honoring a talented early career researcher who is the lead author of a manuscript impacting the practice of radiation oncology will be one of the highlights of ROI’s events at the ASTRO Annual Meeting in October. The Publication Award winner will also receive a $5,000 grant to continue their research. I encourage you to learn more about the award eligibility and criteria
and to submit your nomination by July 7.
Also in 2022, ROI’s research portfolio will expand to include the winners of the “Leveraging Artificial Intelligence for Radiation Oncology” awards. We were thrilled to see another strong response to our annual request for proposals. We are currently reviewing applications and will announce the award-winning investigative teams in June.
Previously funded projects are likewise bearing fruit. This month’s issue of the Red Journal includes an article by Dr. Malcolm Mattes
with results from a survey of radiation oncology departments on their outreach to medical student groups for women and minorities, part of his ROI-funded project to increase diversity in the radiation oncology workforce. Additionally, Dr. Fumiko Chino is receiving the inaugural ASCO Excellence in Equity Award, and she gratefully acknowledges that the ROI grant she received to study financial toxicity in head and neck cancer served as a foundation for her current research
All of this growth is made possible by the contributions of generous donors like you. Help radiation oncology research thrive by making your gift to ROI today
. We are grateful for your support of research that is advancing the field and improving outcomes for patients.
Colleen A.F. Lawton, MD, FASTRO
President, ROI Board of Trustees